INTERNATIONAL PATENT: NORGAARD, ANDERS, KAARE, CATALYST VACCINATION A/S FILES APPLICATION FOR "CANCER VACCINE BASED ON MHC-II EPITOPE SELECTION"

GENEVA, July 19 -- NORGAARD, Anders, Kaare (Lammekaer 72600 Glostrup), CATALYST VACCINATION A/S (Lammekaer 72600 Glostrup) filed a patent application (PCT/DK2025/050007) for "CANCER VACCINE BASED ON MHC-II EPITOPE SELECTION" on Jan 13, 2025. With publication no. WO/2025/149143, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NIELSEN, Morten (Kongevejen 3812840 Holte), HOLST, Peter, Johannes (Tolstojs Alle 142860 Soborg)

Abstract: The present disclosure provides a vaccine against cancers that express MHC-II. That includ...